CI
Cancer IQ Inc.
SEC filingOther Technology · Chicago, IL
Amount raised$4.3Msold at filing
Total offering$6M$1.7M still open
Investors in the raise9count reported to the SEC
FiledMay 26, 2026first sale Nov 1, 2023
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Carladenise Olopade EdwardsDirector
Mark Olopade BakkenDirector
Haibo Olopade LuExecutive Officer, Director
Joel Olopade KrikstonDirector
Olufeyikemi Olopade AyodeleExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.